1. Understanding bioprocessing
1.1. Overview
1.2. Key considerations for the production of biotherapeutics
1.3. Chromatography methods
1.4. Process lifecycle
1.5. Costing
1.6. Facility design
1.7. Testing
1.8. Documentation process
1.9. Conclusion
2. Recombinant manufacturing system
2.1. Overview
2.2. Recombinant DNA
2.3. Expression systems
2.4. Conclusion
3. Cell line development
3.1. Overview
3.2. Overview of protein expression
3.3. Host cell engineering
3.4. Conclusion
3.5. Appendix
4. Upstream equipment and systems
4.1. Overview
4.2. Medium and solution preparation systems
4.3. Bioreactor systems
4.4. Harvest and clarification systems
4.5. Ancillary and peripheral equipment
4.6. Conclusion
5. Upstream processing
5.1. Overview
5.2. Culture media
5.3. Cell culture fermentation
5.4. Conclusion
6. Downstream process
6.1. Overview
6.2. E. coli system : recovery and purification
6.3. Mammalian system purification
6.4. Product concentration
6.5. Analytical methods
6.6. Downstream processing equipment and system components
6.7. Conclusion
7. Process and product lifecycle development
7.1. Overview
7.2. Process development
7.3. Process scale-up
7.4. Technology transfer
7.5. Process characterization and optimization
7.6. Process validation
7.7. Process control strategy
7.8. Testing methods
7.9. Conclusion
8. Quality and compliance systems
8.1. Overview
8.2. Quality system
8.3. Validation master plan
8.4. Good laboratory practices
8.5. Quality control
8.6. Regulatory compliance
8.7. Conclusion
9. Single-use technology
9.1. Overview
9.2. Single-use containers and mixing systems
9.3. Upstream processing
9.4. Connectors and transfer systems
9.5. Sampling
9.6. Downstream processing
9.7. Safety
9.8. Regulatory matters
9.9. Advantages
9.10. Conclusion
10. Advancements and trends in biomanufacturing
10.1. Overview
10.2. Cell line development
10.3. Upstream process intensification
10.4. Downstream
10.5. Continuous manufacturing
10.6. Process analytical technology (PAT)
10.7. Automation
10.8. Conclusion.